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IntroductIon
In the United States, obesity has recently reached pandemic 
levels for a variety of reasons including inactivity and poor 
diet (1,2). The most recent National Health and Nutrition 
Examination Survey (NHANES) showed that 68.3% of those 
studied were considered overweight (BMI ≥25) and 33.9% 
were obese (BMI ≥30) (1). Childhood obesity is particularly 
important as more children are developing what were previ-
ously considered adult diseases, like type II diabetes, high 
blood pressure, elevated serum insulin and dyslipidemia; with 
obese children often progressing to obese adults (2,3).
Genetic models of obesity, such as ob/ob mice, db/db mice, 
Zucker fa/fa obese rats, Agouti yellow mice, and melanocortin 
4 receptor knockout mice, have contributed significantly to the 
understanding of genetic anomalies underlying mechanisms 
that control energy homeostasis (4). Other investigations into 
the aberrant homeostasis responsible for most human obesity 
were carried out using rodent models of diet-induced obes-
ity (DIO) through the administration of high-fat diets (HFD) 
(4). Traditionally, these diets consist of a simple exchange of 
carbohydrate-derived calories with fat-derived calories when 
compared to low fat or chow control diets. However, another 
experimental rodent diet model exists that more accurately 
reflects the variety of highly palatable, energy dense foods 
that are prevalent in Western society and associated with the 
current obesity pandemic: the “cafeteria diet” (CAF) (5,6). 
In this model, animals are allowed free access to standard 
chow and water while concurrently offered highly palatable, 
energy dense, unhealthy human foods ad libitum. This diet 
promotes voluntary hyperphagia that results in rapid weight 
gain, increases fat pad mass and prediabetic parameters such 
as glucose and insulin intolerance (7–10). Moreover, this diet 
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engages hedonic feeding, consistent with the observed volun-
tary hyperphagia, which produces long-lasting neuronal alter-
ations predicted to underlie non-homeostatically regulated 
feeding behaviors associated with some forms of human obes-
ity (11,12). Current US Department of Agriculture labeling 
requirements combined with meticulous laboratory record 
keeping enables a research model of DIO that models progres-
sion to insulin resistance and diabetes.
To date, however, direct comparisons between the CAF 
model and other DIO animal models have not been adequately 
evaluated. Therefore, we embarked on a comprehensive com-
parative study, which demonstrated that the CAF diet is a 
more robust model for human obesity compared to HFD. Our 
hypothesis was that CAF diet would be a more representa-
tive model of human metabolic syndrome; indeed, we provide 
supportive evidence of severe obesity, nonalcoholic steato-
hepatitis (NASH), and glucose intolerance compared to a tra-
ditional lard-based HFD. In addition, as the role of chronic 
low-grade systemic inflammation is increasingly recognized 
to play a part in metabolic syndrome, we demonstrated dra-
matic  CAF-induced  inflammation  in  liver  and  white  and 
brown adipose tissues (BAT). Use of this rapid and potent 
CAF DIO model may be useful to identify novel pathways for 
preventative intervention or therapeutics in the treatment of 
human obesity.
Methods and Procedures
animals
Male Wistar rats (~200 g, 7–8 weeks old) (Harlan Laboratories, Dublin, 
VA) were housed 2 rats/cage in a 12 h light/dark cycle and acclimated 
to the Duke animal housing facility on ad libitum undefined standard 
chow 7001 (“SC,” Harlan Teklad) for 2 weeks before assignment to 
one of four experimental diet groups. Upon initiation of experimental 
diets, rats (avg. 300 g, 9–10 weeks old) were either maintained on ad 
libitum SC as controls or switched to ad libitum defined 45% fat chow 
(“HFD,” Research Diets D06011802), the matched low-fat chow con-
trol (low-fat diet (LFD) Research Diets D07010502), or provided a CAF 
with three human snack foods varied daily in addition to ad libitum SC 
(see Supplementary Table S1 online). The CAF diet foods included 
cookies, cereals, cheese, processed meats, crackers, etc. and were pro-
vided in excess (see Supplementary Table S2 online). Snack items were 
weighed before and after consumption, corrected for drying, and varied 
daily according to the fat, protein, and carbohydrate content as listed in 
Supplementary Table S2 online. Fat intake was the largest macronutri-
ent alteration in CAF rats, however, simple carbohydrate consumption 
was also elevated over HFD and SC rats groups. There are no added 
sugars to the SC diet; any sugars present are derived from whole-grains 
(corn, oats, etc.). The manufacturer Harlan Teklad estimates that simple 
sugars are <5% of total carbohydrates in SC7001. It should be noted 
that the LFD-fed rats also consumed the most simple sugars as a result 
of sucrose substitution for fat in the diet formula (see Supplementary 
Table S3 online).
Two experimental groups of SC and CAF-fed rats (n = 8–9 per diet 
per group) along with one experimental group of SC, LFD, and HFD-fed 
rats (n = 8 per diet) were initiated in parallel overlapping by 4–6 weeks. 
Food consumption and weight gain was monitored daily for 10 weeks 
(Figure 1a–d) to carefully characterize food intake on CAF diet. A sub-
sequent group of experimental animals (n = 8–10 per diet) were fed the 
four respective diets for 15 weeks and analyzed for glucose tolerance, 
insulin sensitivity, metabolic alterations, and tissue mRNA, metabolite 
and phenotypic analysis (Figures 1e,f,2,3,4,5,6, and 7, Supplementary 
Figures S1 and S2 online). Nonesterified fatty acids in plasma were meas-
ured enzymatically (Wako, Richmond, VA) using the Hitachi 911 clinical 
chemistry analyzer (Hitachi, Tokyo, Japan).
Gtt and Itt
For 1 week prior to the glucose tolerance test (GTT) or insulin-toler-
ance test (ITT), animals were acclimated daily to the procedure room 
and handling for injections and blood draws. Rats were fasted over-
night (16 h) and a basal blood draw from the saphenous vein was col-
lected for plasma glucose and insulin measurements 1 h before glucose 
administration. The GTT was performed after 7 weeks on respective 
diets; rats were given an intraperitoneal injection of glucose (1 g/kg 
of body weight; 45% glucose). Blood was obtained from the tail vein 
via nick immediately before glucose injection and every 30 min there-
after for a period of 180 min, and glucose levels were measured with 
BD Logic Glucose Meter (Becton-Dickinson, Franklin Lakes, NJ). ITT 
was performed after 11 weeks where rats were given an intraperitoneal 
injection of insulin (0.75 IU/kg body weight; Humulin Regular; Eli 
Lilly, Indianapolis, IN) and blood glucose was measured as in GTT. The 
homeostasis model assessment was used to calculate approximate insu-
lin resistance (glucose (mg/dl) × insulin/405) (13–16). Plasma insulin 
was measured with a mouse insulin enzyme-linked immunosorbent 
assay (Millipore, Billerica, MA).
tissue collection
After 15 weeks of experimental diet, food was removed for 4–6 h 
before  sacrifice  under  nembutal  anesthesia  for  tissue  collection. 
Cardiac blood was collected and divided into plasma (1.5 ml blood + 
10 µl 1.7 mg/ml EDTA) and serum (clotted for 2 h at room tempera-
ture) aliquots, collecting the supernatant fractions after centrifugation 
(3,800g, 10 min, 4 °C). Pancreas, liver, epididymal white adipose tissue 
(eWAT), and BAT were rapidly isolated, washed in ice-cold phosphate-
buffered saline, patted dry and weighed before freeze clamping and 
snap freezing in liquid nitrogen. A portion of eWAT, BAT, liver, and 
pancreas was placed in a cassette and fixed in Bouin’s fixative over-
night, washed with 70% ethanol, and paraffin-embedded for histologic 
analysis. The remaining portion of the eWAT fat pads was digested 
to obtain the stromal-vascular fraction (SVF) (17). Briefly, tissue was 
immediately immersed into 25 mmol/l HEPES-buffered Dulbecco’s 
modified Eagle’s medium supplemented with 1% fatty acid free low 
endotoxin BSA (A8806; Sigma-Aldrich, St Louis, MO), and minced 
into <10 mg pieces, and filtered through nylon mesh. An lipopolysac-
charide-depleted collagenase cocktail (Liberase 3; Roche Diagnostics, 
Indianapolis, IN) at a concentration of 0.03 mg/ml with 0.2 mg/ml 
DNAse I (Sigma-Aldrich) was added to each tissue filtrate. The sam-
ples were incubated in a shaking water bath at 37 °C for 20–30 min. 
Once digestion was complete, samples were passed through 250-μm 
nylon mesh (Sefar, Depew, NY). The suspension was centrifuged at 
200g for 5 min to pellet the SVF. The SVF was isolated after lysing red 
blood cells and a final spin to remove liquid.
histology
Paraffin-embedded tissues were sectioned at 5 microns and mounted 
for histological staining. Fixative was removed using a graduated series 
of xylenes (Sigma, St Louis, MO), tissues were rehydrated and then 
flushed for an additional 15 min in deionized water to remove any 
remaining fixative. Tissue sections were stained using Harris hema-
toxylin and eosin (H&E) staining or prepared for immunostaining of 
adjacent serial sections. Briefly, immunohistochemisty was carried out 
using serial sections corresponding to H&E-stained tissue sections, 
processed for heat-induced epitope-retrieval using the Dako Target 
Retrieval Solution in conjunction with Dako PT Link (Dako North 
America, Carpinteria, CA). Samples were washed once in Tris-buffered 
saline/Tween 20 and then exposed to 3% hydrogen peroxide to ablate 
the innate peroxidase activity of the tissue. Tissues were then blocked 
in a commercial protein blocking solution (Dako, X0909) and exposed 
to primary antibodies at 4 °C overnight with gentle agitation (1:250). 
The sections were washed three times in Tris-buffered saline/Tween 20 obesity | VOLUME 19 NUMBER 6 | jUNE 2011  1111
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for 15 min each. Biotinylated secondary antibody was added for 1 h at 
room temperature (1:500), and the tissues washed. Visualization of the 
target epitopes recognized by primary and secondary antibody inter-
actions were established using an avidin/biotinylated horseradish per-
oxidase kit (Vectastain Elite ABC; Vector Laboratories, Burlingame, 
CA; PK6100, 1:50) incorporating DAB as the chromogen. The primary 
antibodies used were raised against macrophage markers F4/80 (Santa 
Cruz, Santa Cruz, CA, sc-25830, 1:100) and CD163 (AbD Serotech, 
Raleigh, NC, 1:100), and the tissue sections briefly counterstained 
with Harris hematoxylin to highlight tissue architecture and nuclear 
location. Digital photomicrographs of stained tissues were captured 
using a Nikon Eclipse TS100 equipped with a digital camera using 
TSView7  software,  Version  6.0.2.1  (Tucsen  Imaging  Technology, 
Fujian, China).
Pancreatic islets of Langerhans were visualized by performing immu-
nohistochemistry with an insulin antibody. Briefly, paraffin-embedded 
sections of pancreata were deparaffinized, rehydrated, quenched of 
endogenous peroxidase activity, blocked, incubated with rabbit anti-
anti-insulin primary antibody (Santa Cruz) overnight at 4 °C, and 
incubated with ImmPRESS reagent (peroxidase conjugated anti-rabbit 
Ab; Vector Laboratories) for 30 min NovaRed (Vector Laboratories) 
was used as the substrate for colorimetric detection. Sections were 
lightly counterstained with hematoxylin. Images were acquired using 
an Axio-Observer Z1 microscope (Zeiss, St Louis, MO) fitted with an 
AxioCam HRC camera and operated with Axio-Vision Software, v. 
4.8 (Zeiss). Representative images for each tissue (eWAT, liver, BAT, 
pancreas) from each treatment group were selected. To determine the 
inflammatory state of the eWAT, three randomly selected 10× fields 
were assessed for crown-like structures (CLS) from both H&E stain 
and F4/80 macrophage staining, per study animal. Liver inflammation 
was determined by enumerating the inflammatory loci per 10× field 
using three fields H&E and three fields F4/80 stained for each animal 
(randomly selected). Data are presented as the mean ± s.e.m. for each 
treatment group.
rna isolation
QIAzol Lysis Reagent was used to isolate mRNA from snap-frozen 
SVF pellets with DNAse treatment (RNeasy Lipid Tissue Mini Kit 
mRNA; Qiagen, Valencia, CA). Samples were isolated in duplicate on 
two columns and eluted into the same tube. mRNA quantity and qual-
ity were analyzed by Nanodrop (Thermo Scientific, Wilmington, DE) 
and Bioanalyzer 2100 (Agilent, Wilmington, DE), respectively. For 
quantitative PCR analysis, cDNA was synthesized using IScript (Bio-
Rad, Hercules, CA). Real-time quantitative PCR was completed using 
the Roche LightCycler 480 using LightCycler 480 SW 1.5 software 
and TaqMan Assay on Demand primers for tumor necrosis factor α 
(Applied Biosystems, Carlsbad, CA).
statistics
Data are shown as means ± s.e.m. Analysis was performed using 
ANOVA followed by a Tukey–Kramer honestly significant difference, 
and when appropriate a two-tailed Student’s t-test P < 0.05 using JMP 
(SAS Institute, Cary, NC).
results
caF diet-induced hyperphagia and weight gain
Prior to the start of the study, there were no differences in food 
intake or body weight between animals assigned to experimen-
tal diet groups. We first evaluated food intake, fat intake, and 
body weight changes in male Wistar rats fed four different diets 
(Figure 1 and Supplementary Table S1 online): (i) “SC”: con-
trol rats were continued on standard chow (SC7001) fed from 
birth, which contains ~12% kcal derived from fat (porcine fat 
and linoleic acid); (ii) “CAF”: continued SC7001 access plus 
a daily assortment of three human snack items; (iii) “LFD”: a 
defined standard chow (SC502) with 10% kcal derived from 
fat (lard and soybean oil); (iv) “HFD”-matched to SC502 with 
decreased carbohydrate content and increased lard content 
(45% kcal derived from fat). Rats on the CAF diet consumed 
standard chow at ~15% of that consumed by rats fed standard 
chow only.
Average weekly nutrient intake per rat in a 10-week food 
intake  study  is  summarized  in  Supplementary  Table  S3 
online. All rats consumed ~100 kcal/day/rat except for CAF-
fed rats who significantly consumed about 30% more calo-
ries (Supplementary Table S3 and Figure 1a). HFD-fed rats, 
unlike CAF-fed rats, significantly decreased total gram intake 
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Figure 1  Cafeteria diet (CAF) drives food and fat consumption. 
(a) Male Wistar rats on CAF have elevated food intake in terms of kcal 
compared to standard chow (SC) control, high-fat diet (HFD), and 
low-fat diet (LFD). (*HFD P < 0.05 vs. all; **CAF P < 0.0001 vs. all). 
(b) Upon initiation of diets, only HFD-fed rats decreased food intake in 
grams (g) with an acute increase in CAF-intake. (*CAF P < 0.005 vs. all; 
** CAF P < 0.005 vs. SC and HF; ^HF P < 0.005 vs. all; ^^HF P < 0.005 
vs. SC and CAF). (c) CAF-fed rats consume more fat when compared 
to animals receiving HFD, LFD, or SC. (*CAF and HF P < 0.001 vs. 
SC and LF; ^CAF P < 0.05 vs. HF). (d) CAF-diet fed rats exhibited 
significant weight gain starting at 2 weeks and persisting throughout 
the study. Data are normalized to SC. (*CAF, LFD, or HFD P < 0.05 vs. 
SC, **CAF P < 0.05 vs. SC). (e) After 15 weeks on diet, CAF-fed rats 
exhibited greater total weight gain when compared to SC, LFD, and 
HFD. Although HFD-fed rats also gained weight, there is no difference 
in the weight gain between the HFD and LFD groups, however weight 
gain did reach statistical significance when compared to the SC control 
group. (*HF P < 0.05 vs. SC; **CAF P < 0.05 vs. all). (f) There were no 
changes in body length after 15 weeks on diet. (a–d) were conducted 
on a set of rats fed diet for 10 weeks. (n = 23–24, SC, n = 8 LFD, HFD, 
n = 17 CAF) and (e,f) were conducted on a group of rats fed diet for 15 
weeks (n = 8, SC, LFD, and HFD, n = 10 CAF).1112  VOLUME 19 NUMBER 6 | jUNE 2011 | www.obesityjournal.org
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of the calorically dense diet to normalize caloric consump-
tion by week 2, an effect commonly seen in rodents placed on 
HFD (Figure 1b). Fat intake consumption paralleled percent 
fat content of diet with SC and LFD consuming ~10 kcal/day/
rat, the HFD group at 45 kcal/day/rat, and the CAF-diet group 
at 55 kcal/day/rat (Figure 1c). CAF-fed rats gained the most 
weight on the diet, almost double the weight gain evident in 
SC controls, whereas LFD and HFD-fed rats demonstrated 
similar and intermediate weight gain (Figure 1d). A subse-
quent group was placed on the four experimental diets for 
15 weeks, demonstrating similar and continued weight gain 
(Figure 1e and Supplementary Figure S1 online) with no 
statistical differences in body length among treatment groups 
(Figure 1f).
caF-diet induced hyperglycemia and insulin resistance
At an intermediate time point (7 weeks) on diets, glucose 
homeostasis was maintained irrespective of diet, as blood 
glucose measured in obese and lean rats fasted overnight 
was not significantly different amongst the four diet groups 
(Figure  2a).  However,  insulin  was  approximately  dou-
bled in CAF- and HFD-fed rats compared to SC controls 
(Figure 2b).  Consistent  with  the  observed  intermediate 
body weight phenotype, LFD-fed rats displayed a modest, 
nonsignificant elevation in fasting insulin compared to SC. 
Similarly, homeostasis model assessment of insulin resist-
ance HOMAIR calculations as a measure of insulin sensi-
tivity indicated that CAF- and HFD-fed rats were twofold 
less insulin sensitive than SC controls at just 7 weeks into 
the diets (Figure 2c). After extended exposure to diets (15 
weeks), hyperglycemia became evident in CAF-fed rats only, 
as 3 of 10 exhibited hyperglycemia after a 6 h fast before sac-
rifice with no differences between LFD, HFD, and SC control 
groups (Figure 2d). Based on HOMAIR findings, intraperi-
toneal GTT (IP-GTT) and ITT (IP-ITT) were administered 
to determine the effect of the diets on glucose tolerance and 
insulin action. In line with weight gains, IP-GTT at 7 weeks 
on diets demonstrated that glucose intolerance and insulin 
resistance increased from SC<LFD<HFD<CAF (least resist-
ant to most resistant) (Figure 3a,b), and insulin levels were 
significantly elevated for all diets relative to SC (Figure 3c). 
IP-ITT performed at 11 weeks on diets demonstrated that 
the insulin-mediated drop in glucose was not significantly 
different between diet exposures (Figure 3d,e).
a
B
l
o
o
d
 
g
l
u
c
o
s
e
 
(
m
g
/
d
l
) 400
300
200
100
250
200
150
B
l
o
o
d
 
g
l
u
c
o
s
e
 
(
m
g
/
d
l
)
100
50
100 80
Time (min)
Time (min) Time (min)
60 40 20 0 120140160180
90 60 30 0 −30 120 1501 80 80 60 40 20 0
8
6
4
I
n
s
u
l
i
n
 
(
n
g
/
m
l
)
I
n
v
e
r
s
e
 
A
U
C
(
b
a
s
e
l
i
n
e
 
s
u
b
t
r
a
c
t
e
d
)
2
0
LF
IPGTT-AUC
IPITT-AUC
LFD
HF
*
**
**
**
*
HFD
SC
SC
CAF
LFD HFD SC CAF
0
−5,000
−10,000
−15,000
−20,000
CAF
b
cd
e
A
U
C
(
b
a
s
e
l
i
n
e
 
s
u
b
t
r
a
c
t
e
d
)
25,000
20,000
15,000
10,000
5,000
0
Figure 3  Cafeteria diet (CAF)-fed rats became glucose intolerant. 
(a) Rats fed low-fat diet (LFD) and high-fat diet (HFD) maintained 
similar tolerance to glucose when challenged with intraperitoneal 
glucose tolerance tests (IP-GTT) at 7 weeks on diets. (b) Area under 
the curve (AUC) quantifications for IP-GTT of averaged individual 
animals showed CAF-fed rats developed significant glucose 
intolerance compared to the standard chow (SC)-fed controls. (*P < 
0.05 vs. SC; **P < 0.05 vs. SC and LF). (c) Insulin levels measured 
during IP-GTT at 11 weeks on diets revealed that all animals induced 
insulin secretion in response to glucose injections, however, SC-fed 
rats had lower basal insulin levels and maintained low insulin levels 
during the IP-GTT when compared to the other diet exposed groups. 
(*P < 0.05 CAF and HF vs. SC; **P < 0.05 all vs. SC; n = 8, SC, LFD, 
and HFD, n = 10 CAF). (d) Intraperitoneal insulin-tolerance tests 
(IP-ITT) revealed blunted insulin action in CAF-fed rats challenged 
with 0.7 IU/kg insulin when compared to SC-fed rats, but there were 
no significant differences between diets. HFD-fed and LFD control-
fed rats displayed an intermediate insulin response that did not vary 
significantly between these groups. (e) AUC quantifications for IP-ITT 
of individual animals averaged. (n = 4, SC, LFD, and HFD, n = 5 CAF).
a
G
l
u
c
o
s
e
 
(
m
g
/
d
l
)
150
100
50
0
LFD HFD SC CAF
c
H
O
M
A
I
R
(
g
l
u
c
o
s
e
 
×
 
i
n
s
u
l
i
n
/
4
0
5
) * *
1.5
1.0
0.5
0.0
LFD HFD SC CAF
d
B
l
o
o
d
 
g
l
u
c
o
s
e
 
(
m
g
/
d
l
)
*
500
400
300
200
100
LFD HFD SC CAF
b
I
n
s
u
l
i
n
 
(
n
g
/
m
l
)
5
* * 4
3
2
1
0
LFD HFD SC CAF
Figure 2  Cafeteria diet (CAF)-fed rats displayed hyperglycemia and 
hyperinsulinemia. Insulin sensitivity was evaluated on rats at weeks 
7 and 11 during the 15-week study. (a,b) Fasting glucose levels were 
not different at 7 weeks of age while only standard chow (SC)-fed rats 
maintained low insulin levels, which were significantly different than CAF- 
and high-fat diet (HFD)-fed rats. (c) Homeostasis model assessment of 
insulin resistance (HOMAIR) calculations at 7 weeks on diets indicated 
that CAF and HF groups demonstrated statistically significant elevations 
in insulin resistance compared to SC-fed rats. (*P < 0.05 vs. SC). (d) 
CAF-fed rats had significantly elevated blood glucose after a 6 h light 
cycle fast at 15 weeks on diet (time of sacrifice) compared to SC, while 
low-fat diet (LFD) and HFD maintained normal glucose levels. (n = 8, SC, 
LFD, and HFD, n = 10 CAF). (*P < 0.05 SC to CAF).obesity | VOLUME 19 NUMBER 6 | jUNE 2011  1113
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caF-diet induced elevations in white and brown adipose 
mass, macrophage-containing cls and inflammation
Obese humans with metabolic syndrome accumulate mas-
sive fat depots, which are shown to be chronically inflamed 
(18). To determine whether adiposity in the rodent mod-
els  of  obesity  described  here  parallel  physiologic  indica-
tions of metabolic syndrome described above, we measured 
eWAT and BAT fat pad masses. CAF diet induced nearly a 
tripling of epididymal white and brown adipose mass com-
pared to SC controls. HFD induced no change relative to 
LFD, but both were significantly different than SC and CAF 
(Figure 4a). Similar results were found for omental fat in an 
alternate set of animals after 10 weeks on experimental diets 
(data not shown). Elevations in plasma nonesterified fatty 
acids, another hallmark of metabolic syndrome, paralleled 
increased adipose mass with CAF diet exhibiting the high-
est levels of nonesterified fatty acids, which were significantly 
elevated over SC controls with LFD and HFD at intermediate 
concentrations (Figure 4b).
We next investigated the inflammatory status of eWAT since 
low-level chronic inflammation and macrophage infiltration 
into white adipose tissue is a well-documented phenomenon 
in animal and human obesity (18–20). Studies have shown 
that macrophages are necessary and sufficient to drive obesity 
and induce insulin resistance (15,21,22). Therefore, to exam-
ine whether CAF diet also induced macrophage infiltration 
in eWAT concurrent with increased fat pad size, detailed his-
tologic analysis of eWAT was undertaken (Figure 5). Using 
macrophage marker F4/80, macrophage infiltration was sub-
stantially higher in CAF-fed eWAT compared to SC, LFD, 
and HFD-fed samples (Figure 5i–l). When compared to LFD 
controls, HFD-fed animals also displayed infiltrating macro-
phages although to a lesser extent than detected in CAF vs. 
SC. CLS are histological features found in obese adipose tis-
sue and are demonstrated to be proinflammatory macrophages 
surrounding dying adipocytes, which are hallmarks of obese 
adipose (21). CAF diet induced a significant 14-fold increase 
in CLS over SC while a less than twofold increase was detected 
for HFD vs. LFD (Figure 5m). Likewise, dense areas of cell 
accumulation which stained positive for F4/80 were evident 
only in CAF-fed adipose. Weisberg et al. and Xu et al. dem-
onstrated that macrophages present in the SVF contribute 
most of the inflammatory mediators in obese adipose tissue 
(17,23). Therefore, we focused our efforts on the dramatic CAF 
effects and isolated the SVF from SC and CAF eWAT fat pads. 
Figure 5n reports the quantification of tumor necrosis factor 
α mRNA expression in the SVF from SC control and CAF-fed 
rats, a proinflammatory cytokine well-established to induce 
insulin resistance in obese rodents and humans (24). Tumor 
necrosis factor α was elevated by 1.6-fold in the SVF isolated 
from CAF- vs. SC-fed eWAT, but did not reach statistical sig-
nificance in this sample set.
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not statistically different between each other. (*P < 0.05 vs. SC; n = 4, 
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Figure 5  Epididymal white adipose tissue (eWAT) reveals dramatic 
macrophage infiltration and inflammation in cafeteria diet (CAF)-fed 
rodents. (a–h) ×10 and ×20 hematoxylin and eosin (H&E) stain of 
eWAT from (a,e) low-fat diet (LFD), (b,f) high-fat diet (HFD), (c,g) 
standard chow (SC), and (d,h) CAF. The box indicates areas of interest 
magnified to ×20 imaging when appropriate. Asterisks indicate crown-
like structures (CLS), or areas of macrophage infiltration around 
adipocytes. Arrow indicates inflammatory loci. (i–l) Macrophage marker 
F4/80 was used to identify CLS (*) and areas of cells aggregating 
within inflammatory loci (arrow) (×40). (m) Quantification of CLS 
revealed a significant twofold increase in HFD- vs. LFD-fed adipose 
whereas CAF-fed adipose displayed a 17-fold increase over SC. (*CAF 
P < 0.05 vs. all, ^HFD P < 0.005 vs. all) (n) Pooled stromovascular 
fractions (SVF) from eWAT enriched in adipose-associated 
macrophages demonstrated higher expression of tumor necrosis 
factor α (TNFα) normalized to 18S in CAF-fed rats when compared to 
SC control animals as determined by qPCR. Representative images 
shown. (n = 4, SC, LFD, and HFD, n = 5 CAF). See supplementary 
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Little is known about macrophage infiltration into BAT 
other than increased macrophage infiltration of BAT in a 
transgenic lipodystrophy model (25). We investigated mac-
rophage infiltration of BAT and indeed, compared to the 
normal architecture of SC-fed rats, increasing obesity causes 
enlarged fat droplets around vasculature in BAT with LFD 
and  HFD  amassing  intermediate  lipid  droplets,  and  CAF 
diet inducing substantial fat accumulation. Only CAF-fed 
rats demonstrated large fat droplet accumulation in the BAT 
parenchyma extending from the vasculature (Figure 6a–h). 
This fat deposition is distinct from the WAT surrounding BAT 
on the periphery (data not shown). Both HFD and CAF diets 
induced strong F4/80 positive stained macrophages around 
the vessels, with elevations in CAF and HFD vs. SC and LFD 
controls (Figure 6i–l).
caF-diet induced hepatosteatosis and inflammation
To investigate the effect of the human unhealthy food diet on 
the formation of nonalcoholic fatty liver disease (NAFLD), we 
evaluated serial sections of livers from each diet group. H&E 
staining of liver sections demonstrated normal liver structure 
in SC controls with some macrovessicular fat accumulation 
in LFD-fed rats. HFD and CAF-fed rat livers display minor 
to major microvessicular steatosis, respectively (Figure 7b 
and  d,  respectively).  Steatosis  associated  with  HFD  was 
mixed macro- and microvesicular, localized to the periportal 
(Figure 7j) to midzonal regions and distinctly absent in the 
pericentral regions where normal tissue architecture was con-
served (Figure 7f). Conversely, the CAF diet invoked hepa-
tosteatosis that encompassed the entire liver lobule and was 
microvessicular in nature (Figure 7h,l). Next, we evaluated the 
ability of each diet to promote NASH by visually documenting 
F4/80 positive macrophage/Kupffer cell content and quantify-
ing inflammatory loci, a collection of inflammatory cells pri-
marily consisting of macrophages. LFD- and SC-fed rat livers 
displayed zero to very few inflammatory loci (Figure 7m,o, 
(respectively) and q). Although livers from rats fed HFD and 
CAF diets contained increased inflammatory loci vs. controls, 
there were dramatic differences in the size and localization of 
loci between HFD and CAF animals (Figure 7n,p, (respec-
tively) and q). In livers from HFD-fed rats, F4/80 positive 
macrophages were small and limited to perivascular regions; 
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Figure 6  Brown adipose tissue (BAT) macrophage infiltration and lipid 
droplet accumulation is perivascular. (a–h) ×10 and ×40 hematoxylin 
and eosin (H&E) stain of BAT from (a,e) low-fat diet (LFD), (b,f) 
high-fat diet (HFD), (c,g) standard chow (SC), and (d,h) cafeteria 
diet (CAF). The box indicates area of the ×10 image magnified to 
×40 imaging when appropriate for H&E stained tissues. Lipid droplet 
accumulation was notable in cells along the length of vessels in LFD, 
HFD, and especially CAF-fed tissues. (i–l) F4/80 was used to identify 
macrophages which can be seen as cells staining dark brown (marked 
with #) in (j) HFD and (l) CAF (×40). It is important to note that F4/80 
positive macrophages colocalized to the perivascular regions where 
high lipid accumulation was noted and that CAF F4/80 positive cells 
stained stronger and were more numerous than those in HFD animals. 
Representative images are shown. (n = 4, SC, LFD, and HFD, n = 5 
CAF). See supplementary table s4 online for detailed description.
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Figure 7  Histologic analysis of rat livers demonstrates dramatic 
macrophage infiltration and steatohepatitis in cafeteria diet (CAF)-
fed rodents. (a–l) ×10 and ×40 hematoxylin and eosin (H&E) stain of 
liver from (a,e,i) low-fat diet (LFD), (b,f,j) high-fat diet (HFD), (c,g,k) 
standard chow (SC), and (d,h,l) CAF. Boxes indicate regions magnified 
to ×40 imaging when appropriate and arrows point to inflammatory loci. 
Central veins (CV; e–h) and portal triads (PT; i–l) are marked. Note 
healthy hepatic cord structure in (c) SC-fed livers when compared to 
macrovessicular steatosis in (i) LFD-fed livers and microvessicular 
steatotic livers in (j,l) HFD- and CAF-fed rodents. Lipid accumulation 
in LFD and HFD livers is localized to regions surrounding the (i,j) PT, 
leaving the (e,f) CV architecture intact, whereas in CAF-fed livers, lipid 
accumulation is (h,l) panlobular and the (d,h) hepatic cord architecture 
is disturbed. (m–p) Serial sections relating to images i–l which are 
stained using macrophage marker F4/80 identify areas of cells 
aggregating into inflammatory loci (arrows) around the PT in (n) HFD 
livers and (p) CAF livers (×40). Representative images are shown. (q) 
Quantification of inflammatory loci in livers revealed a significant 1.5-
fold increase in HFD- vs. LFD-fed livers while CAF-fed livers displayed 
more than fivefold increase (*CAF and HFD P < 0.05 vs. SC). Data are 
presented as the mean ± s.e.m. (n = 4, SC, LFD, and HFD, n = 5 CAF). 
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whereas loci from CAF-fed rats were found in both perivascu-
lar regions and within intralobular regions and were notably 
larger compared to HFD-fed animals (Figure 7).
caF-diet induced islet dysfunction
Significantly elevated glucose and insulin levels and evidence 
of insulin resistance by GTT and ITT in the CAF animals led 
us to examine the pancreata by immunohistochemistry. LFD- 
and SC-fed rats displayed normal pancreatic islets with defined 
borders,  whereas  HFD-fed  rats  contained  slightly  hyper-
trophic and disfigured islets. Islets from CAF-fed rats were 
much larger in size, with dramatically distorted architecture 
(see Supplementary Figure S2 online).
dIscussIon
caF: a model for human obesity and metabolic syndrome
DIO is a common tool used to examine metabolic syndrome 
in rodents. The study presented herein was a comprehensive 
physiologic  and  histologic  analysis  between  a  commonly 
used model for DIO (a lard-based HFD), an alternative die-
tary model of energy dense highly palatable cafeteria-style 
foods and controls fed LFD and SC. The CAF diet provides a 
highly relevant model in terms of examining the human diet 
in rodents and comes at a time when the poor eating habits of 
Americans are in the spotlight. Current worldwide increases 
in obesity cannot be accounted for by changes in genetic back-
grounds alone. Therefore, diet combined with previous evo-
lutionary selective pressure for a “thrifty,” energy-conserving 
phenotype from when humans survived in a feast or fam-
ine world is an obvious contributing factor to this epidemic 
(26). Recent NHANES reports demonstrate that 33.6% of the 
American diet is comprised of fat (%kcal) (27). A study by 
the US Department of Agriculture on the US diet indicated 
that ~16% of Americans had overtly poor diets and that 74% 
needed to improve their diets, based on the US Department of 
Agriculture recommended daily allowances (RDA) for grains, 
vegetables, fruits, milk, meat, total fat, saturated fat, cholesterol, 
sodium, and dietary variety (28). Current research indicates 
that childhood obesity and dietary intake statistics also follow 
these trends. Increased snacking on energy dense foods paral-
lels the dramatic increase in childhood obesity, with unhealthy 
snacks currently comprising >27% of an American child’s daily 
caloric intake (29).
With these striking dietary trends in mind, we embarked 
on a study to examine a human diet in rodents compared 
to the traditional rodent diet most researchers use to model 
DIO. Our study has revealed that rats fed human nutrient-
poor foods develop severe metabolic syndrome which is more 
robust than the effect of traditional HFD exposure. CAF-diet 
fed rats exhibited voluntary hyperphagia and grossly elevated 
fat intake which resulted in dramatic and rapid weight gain. 
Furthermore, CAF diet feeding promoted a prediabetic con-
dition with elevated glucose, insulin, and nonesterified fatty 
acids, accompanied by decreased glucose and insulin tolerance. 
In addition, chronically inflamed liver and adipose tissues and 
distorted pancreatic islet architecture were prevalent.
choice of control diet in animal studies
Interestingly,  our  results  show  that  HFD  did  not  induce  a 
significant weight gain compared to LFD controls for up to 
15 weeks of this diet. This suggests that either a longer diet is 
necessary to develop overt metabolic syndrome on the tradi-
tional high-fat lard-based diet or that the diet was started at an 
age that was too late to induce a divergent phenotype in our 
rats. It is likely that if we extended the study further or per-
haps started in younger rats, a larger difference between the 
LFD and HFD could have emerged. An alternative explanation 
is that compared to standard chow SC, the LFD is very high 
in sucrose, with a simple exchange of fat for sugar to engineer 
the lard-based HFD. Indeed, compared to the SC, the LFD 
caused weight gain and moderate insulin resistance despite the 
fact that animals consumed relatively similar grams of food 
and fat calories. One reason could be that SC is undefined and 
contains carbohydrates derived from barley, oats, wheat, and 
corn rather than highly processed carbohydrate sources such 
as cornstarch, sucrose, and maltodextrin comprising the LFD 
diet. The whole-grains in SC contain phytoestrogens and high 
fiber which are protective against insulin resistance and obesity 
(30,31). In addition, the protein and fat sources vary between 
the SC groups. In sum, our varied results between SC and LFD 
chow “controls” demonstrate that chow diets vary widely in 
their effects, which emphasizes the relevance of chow sources 
and compositions, especially with respect to diet and obesity 
studies. A defined diet such as the LFD included in our study, 
which is commonly used as a control for HFD studies, is helpful 
in terms of knowing the composition but also has poor nutri-
tional additives such as processed carbohydrates that can affect 
baseline measurements.
Interestingly, our study revealed that while HFD-fed ani-
mals decreased food intake in terms of total grams to maintain 
caloric intake comparable to LFD and SC control, CAF-fed 
animals lacked this autoregulatory mechanism. The highly pal-
atable diet with varied flavors and textures seems to have disa-
bled the normal homeostatic mechanism for energy balance 
possibly by activating the reward system (32). Energy-dense 
diets have been shown to alter normal appetite regulation 
(33,34). Another finding from this study is that nutritional 
components of the CAF diet have robust effects beyond the 
fat content alone. The CAF and HFD have similar fat contents 
at about 45–50% while their appropriate controls contained 
about 10–12% kcal derived from fat. Despite these relative sim-
ilarities, the CAF-fed rats were hyperphagic, eating 40% more 
calories/day compared to the HFD. Although the CAF diet is 
high in fat, it is also high in sodium, saturated fatty acid, trans-
fatty acids, and cholesterol and low in fiber and micronutrients 
such as vitamin A and calcium. All of these experimental com-
ponents limit the interpretation of the CAF data such that no 
causal conclusions can be made as to the role or mechanism 
of a specific food component such as high-fat or high-sucrose 
exposure to weight gain associated with CAF diet. However, 
this experimental platform, which more accurately reflects 
early onset obesity and its associated pathologies, continues to 
be improved upon from its inception in 1982. Careful selection 1116  VOLUME 19 NUMBER 6 | jUNE 2011 | www.obesityjournal.org
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of unhealthy food components with known nutritional content 
could facilitate a more mechanistic approach to understanding 
the relevant nutrients associated with rapid weight gain and 
progression toward disease states such as metabolic syndrome, 
NASH and type II diabetes.
severe adipose and liver inflammation in caF
Histologic analysis revealed that CAF-fed rats developed path-
ologic abnormalities in epididymal white adipose, brown adi-
pose, liver, and pancreas consistent with metabolic syndrome. 
Chronic low-grade systemic inflammation is now considered to 
be a key component of metabolic syndrome with white adipose 
known to secrete many relevant adipokines (19,21). Visceral, 
not subcutaneous fat, is associated with metabolic syndrome 
in humans and rodents (35,36). It is well-established that mac-
rophages infiltrate into obese adipose and are necessary and 
sufficient to perpetuate the obese state and insulin resistance 
(21). The CAF diet resulted in dramatic macrophage infiltra-
tion of eWAT and significantly increased the formation of 
CLS, hallmarks of inflammatory adipose. Histologic measures 
of inflammation were supported by quantitative PCR analysis 
of the macrophage-enriched SVF of eWAT that demonstrated 
increased expression of tumor necrosis factor α, a cytokine 
proven to be involved in insulin resistance and adipose lipoly-
sis (24). In BAT, we discovered that large lipid droplets accu-
mulate in the cells surrounding vessels, which correlated with 
weight gain in the LFD and HFD-fed rats, with CAF-fed BAT 
demonstrating the most profound lipid droplet accumulation. 
Importantly, this fat accumulation was distinct from any WAT 
that would be on the periphery of the BAT depot. Furthermore, 
we showed for the first time that the macrophage infiltration 
pattern of BAT differed from that of WAT. There were no CLS 
evident  in  BAT;  however,  infiltration  of  macrophages  was 
detected in the perivascular region where large lipid droplet 
accumulation was prevalent. Currently, the role of perivascular 
macrophage accumulation in BAT is unclear.
Another contributing component of metabolic syndrome 
is fatty liver. NAFLD affects over one-third of the American 
population and ranges from hepatosteatosis to steatohepatitis, 
and could result in cirrhosis or hepatocellular carcinoma (37). 
NAFLD is strongly associated with visceral adiposity (38). 
Hepatosteatosis and steatohepatitis lead to liver insulin insen-
sitivity and the inability to blunt gluconeogenesis, which is 
another contributing factor to metabolic syndrome (39). Our 
data indicate that SC rats have healthy livers with no steatosis 
or inflammation and histologically normal hepatic cords and 
other architecture. Hepatosteatosis developed in LFD livers 
with macrovessicular accumulations noted around the portal 
triad regions. In HFD livers, increased steatosis surrounding 
portal triads progressed to a microvessicular phenotype while 
the central vein architecture was preserved. The most extensive 
steatosis and distorted cord architecture was found in CAF-fed 
livers with microvessicular steatosis evident spanning from the 
portal triads to the central veins (panlobular). Macrosteatosis 
is thought to be benign and reversible while microsteato-
sis is considered malignant and precedes liver fibrosis (40). 
Prolonged steatosis can often lead to steatitis or activation of 
inflammatory cells in the liver. NAFLD, which is recognized as 
the hepatic manifestation of metabolic syndrome, is thought to 
occur in a two-hit manner with lipid accumulation followed by 
chronic inflammation, such as occurs with obesity (41). Like 
in adipose, it is thought that hepatosteatosis promotes the Th1 
proinflammatory response suggesting that Kupffer cells could 
be polarized toward a proinflammatory phenotype, contribut-
ing to insulin resistance (42). Kupffer cells are resident liver 
macrophages and the primary source of liver inflammatory 
cytokines (41). Several groups have recently demonstrated that 
Kupffer cell activation is necessary to produce hepatic insulin 
resistance (42,43). Large Kupffer cells are thought to localize 
in the periportal zone and exhibit higher phagocytosis, pro-
tease activity, and inflammatory potential than smaller Kupffer 
cells in midzonal and pericentral regions (41). Interestingly, 
we detected numerous small loci of inflammatory cells present 
in HFD-fed livers, which accumulated around the portal triad 
regions. In the CAF-fed model however, inflammatory loci 
were larger and infiltrates were evident not only in the por-
tal triad regions but also in the midzonal, intralobular regions. 
During steatosis, Kupffer cells display a diffuse localization 
whereas in NASH patients, Kupffer cells migrate to and aggre-
gate around the pericentral regions (44). In the present study, 
the CAF liver phenotype with inflammatory loci both at the 
portal triads and within midzonal regions indicated macro-
phage migration from the portal triad to central vein and sug-
gests the malignant progression from NAFLD to NASH.
Taken together, we have demonstrated in a comparative 
study that the CAF is a more robust model of metabolic 
syndrome than lard-based HFD and that the rapid-onset of 
weight gain, obesity, multiorgan dysfunctions and pathologies 
observed in the CAF model more closely reflect the modern 
human condition of early onset obesity. The CAF diet, while 
labor intensive and “untraditional,” may be the best model to 
emulate modern human obesity trends.
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